🧠 AI clinical summary is being generated for this article and will appear shortly.
Source: MHRA · Read original ↗
Advice for healthcare professionals on the reclassification of codeine linctus to a prescription-only medicine (POM), following a public consultation.
This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.